Thanking all the FCQ elites, delegates, IDC presenters, speakers, moderators, well-wishers, guests, invitees and co-hosts for your contributions to NCRM NICHE 2018. The pictures will be uploaded soon.


Prof. Dr. Jun Hirabayashi
National Institute of Advanced Industrial Science and Technology (AIST), Biotechnology Research Institute for Drug Discovery (BRD), Japan

Prof. Dr. Jun Hirabayashi is the Prime senior researcher of Biotechnology Research Institute for Drug Discovery at the National Institute of Advanced Industrial Science and Technology (AIST), Japan. He also serves as the Director of Japan Consortium for Glycoscience and Glycotechnology (JCGG) and Councilor, The Japanese Society of Carbohydrate Research (JSCR). His main research fields include Biochemistry, Glycoscience, Glycotechnology and Lectin Engineering. Dr. Hirabayashi's achievements include him being the first to report a covalent primary structure of B-galactoside binding from embryonic chick and was involved in the naming of this family of protein, i.e., galectins. Also, he cloned a cDNA for human galectin-1 and expressed it as a recombinant protein for the first time. Dr. Hirabayashi is also the inventor of "slalom chromatography", which is a novel separation phenomenon accidentally observed for relatively large DNA (>10 kbp) when attempting phage DNA purification to exclude smaller RNA molecules by means of gel-permeation chromatography. Dr. Hirabayashi also developed a unique lectin affinity-capturing method named "glyco-catch" which was later up-graded to a more sophisticated system by his collaborators. Before developing these advanced analytical systems, he has had strongly in mind "Glycomics, coming of age" in the 21st Century, and proposed Glycome Project on the stage of C. elegans (the first multicellular organism, of which genome was determined) in the occasion of GlycoXV, International Symposium on Glycoconjugates held in Tokyo in 1999 .With these achievements evaluated highly, Dr. Hirabayashi moved in November, 2002 by invitation to AIST, the biggest national institute in Japan, and was responsible to development of a new glycan profiling system under the national project Structural Glycomics.

Prof. Dr. G. Ian Gallicano
Department of Biochemistry and Molecular & Cell Biology, Georgetown University Medical Center, Washington, DC, USA

Dr. G. Ian Gallicano was trained as a graduate student primarily as an electron microscopist looking at the ultrastructure of mammalian eggs and embryos. That training was followed by a change in direction where he identified specific signaling mechanisms regulating the initial stages of embryogenesis when the fertilized egg becomes an embryo. He was then trained with Elaine Fuchs (Member of the National Academy of Sciences) at the University of Chicago in the Howard Hughes Medical Institute, as a post-doctoral fellow. There, he was immersed in molecular biology including knockout and transgenic technologies. He brought those technologies to Georgetown University in 2000, where he was asked to take over the Directorship of the Transgenic Core facility. Overall, Dr. Gallicano worked on embryonic stem cells (Mouse) and adult stem cells for the past 20 years and he has published over 60 papers on the topic. Although, the focus of his laboratory is understanding organogenesis and organ growth in early mammalian development, their lab uses this developmental focus to their advantage to increase successful outcomes for their stem cell work.


Dr. Takeyoshi Shimoji
Consultant Neurosurgeon & President- Okinawa Pref. Nanbu Medical Center and Children's Medical Center; Consultant Neurosurgeon, Amekudai Hospital, Okinawa, Japan

Dr. Shimoji graduated from the Faculty of Medicine, Juntendo University, Japan and was a Resident in Neurosurgery in Juntendo University, Japan and then in Northwestern Medical School, USA. He is a Japanese Board certified Neurosurgeon. After his Doctorate in Medicine he joined as Consultant Neurosurgeon in Mambu Hospital, Okinawa Prefecture, Japan. He later served as the Chief Consultant of Medical Services and Vice President of Naha Hospital, Okinawa, Japan. At present he is the President- Okinawa Pref. Nanbu Medical Center and Children's Medical Center and is a Consultant Neurosurgeon at the Amekudai Hospital in Okinawa, Japan. He has pioneered a novel procedure known as Shimoji's Cranioplasty Yielding Life-quality Improvements in MIld Trigonocephaly (SCYLIMIT)